Leptin in Athletes: What the “Fat Hormone” Reveals About Energy Availability and Neuroendocrine Function
Table of Contents
Key Takeaways: Leptin in Athletes
- Leptin is a hormone produced by fat cells that helps the brain monitor energy availability rather than simply body fat.
- In athletes, low leptin is driven primarily by inadequate energy availability—not by exercise alone.
- Prolonged dieting and low energy availability can substantially reduce leptin within days, making it one of the body’s early physiological adaptations to an energy deficit.
- Low leptin is associated with broader endocrine changes affecting appetite regulation, reproductive function, bone metabolism, and other systems, but it is only one part of a much larger physiological response.
- Female athletes who maintain very low energy availability for prolonged periods may develop functional hypothalamic amenorrhea, increasing concern for impaired bone health and other consequences of RED-S.
- Measuring leptin is not part of routine athlete blood work and rarely changes clinical management. In most situations, it is more valuable for understanding physiology than guiding diagnosis or treatment.
- A low leptin concentration should always be interpreted alongside body composition, dietary intake, training load, symptoms, and the overall clinical picture rather than in isolation.
- For most athletes, correcting inadequate energy intake and restoring appropriate energy availability is far more important than trying to normalize a leptin value itself.
Introduction: Leptin in Athletes
Leptin is not part of routine blood testing for most athletes, and in everyday clinical practice its concentration rarely changes management—particularly in primary care. In my view, this distinction is important: leptin is physiologically interesting, but that does not automatically make it a useful diagnostic test. Circulating leptin can decrease during low energy availability, yet its value as a standalone screening or predictive marker in athletes has not been established. For that reason, I would not generally interpret a single leptin result as proof of underfueling or use it in isolation to guide clinical decisions.
Leptin is secreted by fat cells in rough proportion to the body’s stored energy and provides the brain with information related to adipose reserves and recent changes in energy balance [1]. When energy availability becomes inadequate, leptin can decrease within days in controlled studies, sometimes while several other measured hormones remain unchanged [7][8]. This makes leptin useful for understanding how the body adapts to an energy deficit, even when measuring its circulating concentration offers limited practical value in an individual athlete.
From a clinical perspective, leptin is therefore more relevant as part of the underlying physiology than as a routine laboratory marker. Its signaling pathways interact with appetite regulation, neuroendocrine function, and the effects of certain medications. Some drugs may influence leptin signaling or appetite directly, while others may affect the same regulatory network indirectly through related neurotransmitters and hormonal pathways. These mechanisms can be clinically meaningful even when leptin itself is not measured.
This article examines what leptin in athletes reflects, how training and underfueling influence it, why leptin-related physiology matters for bone health and menstrual function, what the assessment and treatment research actually supports, and how athletes and coaches can interpret the subject without confusing biological plausibility with proven clinical usefulness.
Why Leptin in Athletes Matters
Understanding leptin in athletes begins with leptin’s central role in the regulation of energy homeostasis. As an adipocyte-derived hormone, leptin serves as a key afferent signal to the central nervous system, where it contributes to the regulation of food intake, energy expenditure, and glucose balance [3].
Understanding leptin in athletes begins with its role as an adipose-derived signal involved in central energy homeostasis. Circulating leptin generally reflects stored energy reserves, while declining leptin contributes to the body’s adaptive response to energy insufficiency [3]. In athletes, this becomes relevant when training-related energy expenditure is not adequately matched by energy intake, whether intentionally or unintentionally [4–6].
The IOC’s Relative Energy Deficiency in Sport (REDs) framework recognizes suppressed leptin as one of the metabolic-hormone changes associated with problematic low energy availability [4]. A 2018 IOC update on RED-S noted that severely energy-deficient women in a controlled trial showed significant decreases in leptin, T3, and IGF-1, along with an increase in ghrelin, while moderately deficient women mainly showed a drop in resting metabolic rate [5]. Because this pattern shows up consistently across independent studies, these findings have made leptin in athletes an important research marker of the endocrine response to low energy availability, although its clinical utility for individual athletes remains uncertain.
From a clinical perspective, however, this does not mean that leptin is commonly measured or that its concentration has an established role in routine athlete assessment. In primary care, leptin testing is rarely relevant, and when it is used clinically, it tends to belong to highly specialized settings, such as selected tertiary-care evaluations involving uncommon metabolic or gastrointestinal disorders. In practice, the main value of leptin in sports medicine is therefore explanatory: it helps clarify how inadequate energy availability may influence appetite regulation and neuroendocrine function, even though measuring leptin itself usually adds little to the assessment of an individual athlete.
Mechanisms: How Training Affects Leptin in Athletes
Leptin Appears to Track Energy Availability More Closely Than Exercise Stress Itself
A frequently cited experiment isolated the two variables that get tangled together in real athletes — exercise itself, and the caloric shortfall that often accompanies it. Researchers held energy intake constant while manipulating exercise energy expenditure in young women, and found that restricting energy availability suppressed the 24-hour mean and the amplitude of leptin’s daily rhythm, while exercise stress on its own did not produce that effect [6]. The suppression from dietary restriction alone was more pronounced than the suppression seen when the same energy deficit was created through exercise, which the authors attributed to the body shifting toward fat oxidation and sparing glucose during exercise [6].
Available controlled evidence suggests that energy availability is a more important determinant of leptin suppression in athletes than exercise stress alone. Two athletes doing identical workouts can have very different leptin trajectories depending on whether their eating keeps pace.
I remember this clearly from periods when I was dieting into a lower weight class. As the diet progressed, my normal sense of satiety gradually seemed to disappear. I could eat a substantial meal and still feel as though I could continue almost indefinitely. It would be too simplistic to attribute that experience to leptin alone, because ghrelin and several other appetite-regulating signals are also involved. Still, it illustrates how prolonged energy restriction can feel in practice: hunger may become more persistent, satiety less reliable, and eating increasingly difficult to regulate by internal cues alone.
Short-Term Restriction Produces Large, Measurable Drops
Controlled feeding studies give a sense of scale. In exercising men held at low energy availability for four days, leptin fell by 53–56% regardless of whether the energy deficit was achieved through dietary restriction alone or through a combination of restriction and exercise, while testosterone, IGF-1, T3, and ghrelin were unaffected over that short window [7]. A newer systematic review pooling thirteen experimental short-term low-energy-availability studies (145 participants total) found leptin decreased consistently across nearly all of them, alongside early shifts in bone turnover markers, while iron status, inflammatory markers, estradiol, and progesterone were comparatively stable in the short term — though the same review flagged early testosterone changes alongside leptin and bone turnover markers as among the adaptations that did shift [8].
From a clinical perspective, however, these findings are more physiologically interesting than immediately actionable. They show that leptin can respond quickly to an energy deficit, but they do not establish that measuring leptin improves diagnosis, treatment decisions, or follow-up in routine practice. In most everyday clinical settings, the athlete’s history, training load, dietary intake, menstrual or reproductive function, body composition, symptoms, and other relevant findings remain far more useful than documenting the exact magnitude of a short-term leptin decline.
Leptin in Athletes Tracks Body Fat Closely
Because leptin is secreted by adipocytes, it correlates strongly with body fat percentage. In a study of male endurance athletes tracking hormone responses across low- and high-volume training weeks, leptin correlated with DXA-measured body fat percentage at r = 0.88 during a high-volume week and r = 0.93 during a low-volume week (both p < 0.001), a stronger relationship than the one observed between testosterone and body fat [9]. If leptin happens to be measured in an athlete, the result needs to be interpreted in the context of body composition. A low value in a very lean athlete may partly reflect low adiposity rather than recent underfueling, and a change from an individual baseline may offer some additional context. Even so, leptin is not a routine test in athlete assessment, and in most clinical situations the result is better viewed as “nice to know” than as a finding that directly changes diagnosis or treatment.
How Acute and Prolonged Exercise Affect Leptin in Athletes
Short exercise bouts under approximately one hour generally don’t appear to produce consistent independent changes in leptin; most apparent short-term reductions are attributed to circadian rhythm or hemoconcentration rather than to the exercise itself [10]. Longer sessions are different — reviews of the acute-exercise literature have reported lower leptin after some prolonged running and cycling protocols lasting one to three hours, an effect attributed largely to diurnal decline independent of the exercise itself, though findings are influenced by sampling time, energy imbalance, and changes in plasma volume, and exercise that produces a large enough energy imbalance separately suppresses the leptin rhythm directly [10]. A systematic review and meta-analysis found that both exercise training alone and exercise combined with caloric restriction reduced plasma leptin, with a larger pooled effect in studies that included caloric restriction. The authors noted that individual studies combining caloric restriction with exercise commonly reported reductions exceeding 50%, including during some relatively short interventions, and suggested that caloric restriction was the main contributor among already-trained participants [11].
Impact: Reproductive Function, Bone Health, and Immunity
Hypothalamic Amenorrhea and the Leptin–Reproduction Link
The clearest human evidence for a causal contribution of leptin deficiency comes from clinical trials in women with hypoleptinemic functional hypothalamic amenorrhea (FHA) — a condition encountered particularly in endurance and leanness-focused sports and commonly associated with low energy availability, although its etiology is multifactorial. In an early controlled study, eight women with exercise- or low-weight-related hypothalamic amenorrhea received recombinant leptin for up to three months, compared against six separate untreated controls, and the treated group showed improvements in reproductive and neuroendocrine markers [12]. A subsequent randomized, double-blind, placebo-controlled trial using metreleptin over 36 weeks went further, demonstrating that metreleptin increased the likelihood of menstrual recovery and improved abnormalities across the gonadal, thyroid, growth hormone, and adrenal axes in women with hypothalamic amenorrhea [13]. This trial is one of the few in this field to establish a causal — not just correlational — role for leptin in contributing to the reproductive shutdown seen with energy deficiency [13].
In practice, this physiology becomes especially relevant in athletes who maintain a very low body-fat level or diet aggressively for performance or weight-class reasons. Sports such as gymnastics, figure skating, and weight-class disciplines may create strong incentives to remain lean, and in some female athletes menstrual cycles can become irregular or stop altogether. When I encounter this pattern, I do not interpret it as a leptin problem in isolation. Rather, it raises concern about the broader effects of low energy availability on the hypothalamic–pituitary–gonadal axis, with leptin representing one part of that adaptive response.
Bone Health
Hypothalamic amenorrhea can adversely affect bone through estrogen deficiency and other endocrine changes, while leptin may also influence bone metabolism through additional pathways. In women with hypoleptinemia and hypothalamic amenorrhea, two years of continued metreleptin treatment increased bone mineral density and content at the lumbar spine by 4–6% in the four participants who completed the full study period, although changes at the whole body, hip, and radius were not significant [14]. A 2025 review on functional hypothalamic amenorrhea in adolescent athletes similarly names metreleptin as a therapy shown to restore menstrual function and improve bone metabolism markers, while noting that its association with further weight loss has limited its adoption as a standard treatment [15].
Clinically, the concern is that these skeletal effects may remain largely silent during adolescence and early adulthood. A young athlete may feel well, continue training, and have no obvious bone-related symptoms despite prolonged menstrual dysfunction and impaired bone accrual. Years later, it is reasonable to consider whether such a period may have contributed to reduced peak bone mass or later osteoporosis risk. In an individual patient, however, that contribution is usually difficult to demonstrate retrospectively because bone health is shaped by many factors across the lifespan.
Immune Function
Low energy availability is also associated with endocrine and immune alterations, including lower leptin in some settings. A recent review on the endocrine effects of REDs notes that in animal models, falling leptin, alongside cortisol elevation and pro-inflammatory cytokine changes, is linked to an altered immune balance, and separately cites higher rates of upper respiratory and gastrointestinal infections in observational data from amenorrheic elite distance runners and Olympic athletes flagged as at risk for low energy availability — though leptin’s independent contribution to human infection risk remains uncertain [2].
From a clinical perspective, this is not especially surprising. In more severe states of malnutrition, impaired immune function is a familiar part of the broader physiological deterioration that accompanies inadequate energy and nutrient intake. Fortunately, athletes rarely present with caloric restriction severe enough to resemble advanced clinical malnutrition. In practice, other warning signs often become apparent first, including pronounced weakness, impaired performance, dizziness, electrolyte disturbances, cardiovascular instability, or arrhythmias. When the deficit becomes sufficiently severe to produce systemic complications, the patient is no longer dealing with a sports-performance issue alone and may require urgent medical assessment or inpatient internal-medicine care.
Conclusion: Leptin in Athletes
Leptin provides a useful physiological framework for understanding how an athlete’s body responds when energy intake no longer keeps pace with training demands. Its concentration can fall rapidly during low energy availability, particularly during prolonged dieting, and this decline forms part of a broader adaptive response involving appetite regulation, reproductive function, bone metabolism, thyroid signaling, and other neuroendocrine systems. In athletes, these effects may become most visible when persistent hunger increases, satiety becomes less reliable, menstrual cycles become irregular or stop, performance declines, or other signs of underfueling begin to emerge.
At the same time, the biological importance of leptin should not be confused with the clinical usefulness of measuring it. Leptin is not a routine blood test in athlete assessment, and a single low result cannot distinguish reliably between low body fat, recent underfueling, chronic low energy availability, or other contributing factors. In most clinical situations, the result is therefore more useful for explaining physiology than for directing diagnosis or treatment. The athlete’s history, dietary intake, training load, symptoms, menstrual or reproductive function, body composition, and overall clinical picture remain far more important.
The practical message is that low leptin should not be viewed as an isolated hormonal disorder that needs to be corrected on its own. It is better understood as one component of the body’s attempt to conserve energy when availability becomes inadequate. Restoring sufficient energy intake and addressing the underlying training–nutrition imbalance remain more clinically relevant than attempting to normalize a laboratory value. Metreleptin research has demonstrated a causal role for leptin deficiency in selected women with hypoleptinemic functional hypothalamic amenorrhea, but this highly specific evidence should not be generalized into routine treatment or screening of athletes. For most athletes, leptin is therefore an important part of the explanation—but rarely the test that determines what should be done next.
Bibliography
[1] https://www.sciencedirect.com/science/article/abs/pii/S0026049524002841
[2] https://academic.oup.com/edrv/article/45/5/676/7629683
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12751087/
[4] https://doi.org/10.1136/bjsports-2023-106994
[5] https://journals.humankinetics.com/view/journals/ijsnem/28/4/article-p316.xml
[6] https://pubmed.ncbi.nlm.nih.gov/10644535/
[7] https://doi.org/10.1080/02640414.2016.1142109
[8] https://onlinelibrary.wiley.com/doi/10.1111/sms.70249
[9] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11547639/
[10] https://pubmed.ncbi.nlm.nih.gov/12324651/
[11] https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0288730
[12] https://www.nejm.org/doi/full/10.1056/NEJMoa040388
[13] https://www.pnas.org/doi/10.1073/pnas.1015674108
[14] https://www.sciencedirect.com/science/article/abs/pii/S0026049511001569
[15] https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1709695/full
